Alerts will be sent to your verified email
Verify EmailTHEMISMED
Themis Medicare
|
Hester Biosciences
|
Shree Ganesh Remed.
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
3.59 % | 1.53 % | 2.02 % |
Financials
|
|||
5 yr Average ROE
|
16.7 % | 12.14 % | 20.92 % |
5yr average Equity Multiplier
|
1.64 | 2.11 | 1.41 |
5yr Average Asset Turnover Ratio
|
0.69 | 0.45 | 0.84 |
5yr Avg Net Profit Margin
|
14.74 % | 12.98 % | 18.24 % |
Price to Book
|
3.31 | 5.04 | 7.17 |
P/E
|
29.56 | 48.87 | 32.82 |
5yr Avg Cash Conversion Cycle
|
83.02 Days | 83.43 Days | 57.72 Days |
Inventory Days
|
75.24 Days | 106.53 Days | 52.82 Days |
Days Receivable
|
154.39 Days | 94.77 Days | 53.79 Days |
Days Payable
|
149.43 Days | 142.53 Days | 63.57 Days |
5yr Average Interest Coverage Ratio
|
6.9 | 7.46 | 61.66 |
5yr Avg ROCE
|
18.52 % | 12.53 % | 24.99 % |
5yr Avg Operating Profit Margin
|
19.18 % | 24.84 % | 25.8 % |
5 yr average Debt to Equity
|
0.34 | 0.74 | 0.2 |
5yr CAGR Net Profit
|
11.92 % | -8.32 % | 35.12 % |
5yr Average Return on Assets
|
10.34 % | 5.95 % | 15.1 % |
Shareholdings
|
|||
Promoter Holding
|
67.15 % | 53.73 % | 72.8 % |
Share Pledged by Promoters
|
2.43 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.03 % | 0.0 | 3.68 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.02 % | 0.0 |
Themis Medicare
|
Hester Biosciences
|
Shree Ganesh Remed.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Verticals
|
Verticals
|
-
|
-
|